BARER SOL J

Average Profitability
<0.0001%
Insider Buys Quantity
30
Insider Buys Sum
$14.01M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of BARER SOL J

The largest purchase of all time was on 2013-04-16 and amounted to 1500000 shares of InspireMD, Inc. for $3M.

Biography of BARER SOL J

No biography is available at this moment.

2023-03-30PurchaseNexImmune, Inc.
NEXI
director
400,000
1.6133%
$0.41$164,120-33.95%
2022-11-17PurchaseNexImmune, Inc.
NEXI
director
75,000
0.3304%
$0.48$35,918-31.42%
2022-11-16PurchaseNexImmune, Inc.
NEXI
director
125,000
0.4914%
$0.48$60,300-39.22%
2022-05-31PurchaseNexImmune, Inc.
NEXI
39,280
0.1647%
$2.19$85,894-79.21%
2022-03-23PurchaseNexImmune, Inc.
NEXI
10,000
0.0442%
$2.67$26,653-73.33%
2022-03-22PurchaseNexImmune, Inc.
NEXI
30,000
0.1195%
$2.41$72,300-73.33%
2022-03-21PurchaseNexImmune, Inc.
NEXI
30,000
0.1362%
$2.14$64,080-65.05%
2022-03-18PurchaseNexImmune, Inc.
NEXI
30,000
0.1276%
$2.11$63,210-65.94%
2021-02-17PurchaseNexImmune, Inc.
NEXI
director
60,000
0.3342%
$17.00$1.02M-42.01%
2019-06-04PurchaseTeva Pharmaceutical Industries Limited
TEVA
director
209,000
0.0193%
$9.60$2.01M-2.94%
2019-06-03PurchaseTeva Pharmaceutical Industries Limited
TEVA
director
222,000
0.0205%
$8.98$1.99M+3.93%
2016-03-21PurchaseInspireMD, Inc.
NSPR
director
847,458
8.8183%
$0.59$500,000-80.33%
2015-10-06PurchasePDS Biotechnology Corporation
PDSB
director
90,000
0.2016%
$11.00$990,000-45.67%
2015-03-09PurchaseInspireMD, Inc.
NSPR
director
5M
11.0072%
$0.47$2.38M-39.33%
2014-11-07PurchaseInspireMD, Inc.
NSPR
director
192,308
0.512%
$1.30$250,000-76.61%
2014-05-13PurchaseInspireMD, Inc.
NSPR
director
90,400
0.2749%
$2.44$221,028-88.16%
2014-05-12PurchaseInspireMD, Inc.
NSPR
director
9,600
0.0296%
$2.42$23,203-87.87%
2013-05-31PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1198%
$2.26$90,400
2013-05-30PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1185%
$2.07$82,800
2013-05-29PurchaseInspireMD, Inc.
NSPR
director
40,000
0.1169%
$2.09$83,600
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.